# Sensient Technologies Corp: overview

SXT · NYSE · CIK 310142 · [Materials](/sectors/materials.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/sxt.md) · [Financials](/companies/sxt/financials.md) · [Filings](/companies/sxt/filings.md) · [Insiders](/companies/sxt/insiders.md)

Latest reported revenue: [$455.8m](/filings/0001140361-26-041259.md) for Q3 FY2026, three months to 2026-09-30, from the 10-Q filed Oct 30, 2026 (XBRL us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax, accession 0001140361-26-041259).

## Last eight quarters

| Line item | Unit | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) | Q3 FY2026 (2026-09-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [376 d](/filings/0001140361-26-005311.md) | [392](/filings/0001140361-26-019060.md) | [414](/filings/0001140361-26-031094.md) | [412](/filings/0001140361-26-041259.md) | [393 d](/filings/0001140361-26-005311.md) | [436](/filings/0001140361-26-019060.md) | [462](/filings/0001140361-26-031094.md) | [456](/filings/0001140361-26-041259.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [11.2% d](/filings/0001140361-26-005311.md) | [13.6%](/filings/0001140361-26-019060.md) | [13.9%](/filings/0001140361-26-031094.md) | [14.0%](/filings/0001140361-26-041259.md) | [9.7% d](/filings/0001140361-26-005311.md) | [15.3%](/filings/0001140361-26-019060.md) | [16.6%](/filings/0001140361-26-031094.md) | [15.9%](/filings/0001140361-26-041259.md) |
| Net margin | % | [8.0% d](/filings/0001140361-26-005311.md) | [8.8%](/filings/0001140361-26-019060.md) | [9.1%](/filings/0001140361-26-031094.md) | [9.0%](/filings/0001140361-26-041259.md) | [6.5% d](/filings/0001140361-26-005311.md) | [10.1%](/filings/0001140361-26-019060.md) | [11.1%](/filings/0001140361-26-031094.md) | [10.6%](/filings/0001140361-26-041259.md) |
| Diluted EPS | $ per share | not reported | [0.81](/filings/0001140361-26-019060.md) | [0.88](/filings/0001140361-26-031094.md) | [0.87](/filings/0001140361-26-041259.md) | not reported | [1.04](/filings/0001140361-26-019060.md) | [1.20](/filings/0001140361-26-031094.md) | [1.13](/filings/0001140361-26-041259.md) |
| Free cash flow | $m | [(1.7) d](/filings/0001140361-26-005311.md) | [(25.8)](/filings/0001140361-26-019060.md) | [27.1 d](/filings/0001140361-26-031094.md) | [24.2 d](/filings/0001140361-26-041259.md) | [12.9 d](/filings/0001140361-26-005311.md) | [(42.4)](/filings/0001140361-26-019060.md) | [9.7 d](/filings/0001140361-26-031094.md) | [2.2 d](/filings/0001140361-26-041259.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax. Derived values: 12-month figure less the 9-month figure.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment. Derived values: 12-month figure less the 9-month figure; 6-month figure less the 3-month figure; 9-month figure less the 6-month figure.

## Last five fiscal years

| Line item | Unit | FY2021 (2021-12-31) | FY2022 (2022-12-31) | FY2023 (2023-12-31) | FY2024 (2024-12-31) | FY2025 (2025-12-31) |
| --- | --- | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1,380](/filings/0001140361-24-008963.md) | [1,437](/filings/0001140361-25-005084.md) | [1,456](/filings/0001140361-26-005311.md) | [1,557](/filings/0001140361-26-005311.md) | [1,612](/filings/0001140361-26-005311.md) |
| Gross margin | % | not reported | not reported | not reported | not reported | not reported |
| Operating margin | % | [12.3%](/filings/0001140361-24-008963.md) | [13.7%](/filings/0001140361-25-005084.md) | [10.6%](/filings/0001140361-26-005311.md) | [12.3%](/filings/0001140361-26-005311.md) | [12.8%](/filings/0001140361-26-005311.md) |
| Net margin | % | [8.6%](/filings/0001140361-24-008963.md) | [9.8%](/filings/0001140361-25-005084.md) | [6.4%](/filings/0001140361-26-005311.md) | [8.0%](/filings/0001140361-26-005311.md) | [8.3%](/filings/0001140361-26-005311.md) |
| Diluted EPS | $ per share | [2.81](/filings/0001140361-24-008963.md) | [3.34](/filings/0001140361-25-005084.md) | [2.21](/filings/0001140361-26-005311.md) | [2.94](/filings/0001140361-26-005311.md) | [3.16](/filings/0001140361-26-005311.md) |
| Free cash flow | $m | [84.4](/filings/0001140361-24-008963.md) | [(67.3)](/filings/0001140361-25-005084.md) | [81.8](/filings/0001140361-26-005311.md) | [97.9](/filings/0001140361-26-005311.md) | [38.4](/filings/0001140361-26-005311.md) |

- Revenue. XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Gross margin (gross profit / revenue). XBRL Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Operating margin (operating income / revenue). XBRL Operating income: us-gaap:OperatingIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Net margin (net income / revenue). XBRL Net income: us-gaap:NetIncomeLoss; Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax.
- Diluted EPS. XBRL Diluted EPS: us-gaap:EarningsPerShareDiluted.
- Free cash flow (operating cash flow − capital expenditure). XBRL Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities; Capital expenditure: us-gaap:PaymentsToAcquirePropertyPlantAndEquipment.

Each value links to the filing it came from. d marks a derived value. A ratio is not reported when any input is missing.

## Insider purchases and sales

The last 20 open-market transactions on Form 4 (codes P and S). Reported price is as stated on the form, not a market price. [All insider transactions](/companies/sxt/insiders.md)

None in coverage.

## Funds that report holding it

From each manager’s latest Form 13F, largest reported value first. Reported value is as filed: filing data, not a price. [All funds](/funds.md)

| Fund | Quarter ended | Reported value | Shares | Put or call | Change on the quarter before |
| --- | --- | ---: | ---: | --- | --- |
| [BlackRock, Inc.](/funds/2012383.md) | 2026-06-30 | $818.4m | 6,638,033 |  | Added +355,902 |
| [VANGUARD PORTFOLIO MANAGEMENT LLC](/funds/2100121.md) | 2026-06-30 | $342.3m | 2,776,450 |  | Added +32,375 |
| [Freemont Capital Pte Ltd](/funds/1796107.md) | 2026-06-30 | $252.7m | 2,049,782 |  | Reduced −4,255,132 |
| [VANGUARD CAPITAL MANAGEMENT LLC](/funds/2100119.md) | 2026-06-30 | $236.5m | 1,918,307 |  | Added +5,414 |
| [STATE STREET CORP](/funds/93751.md) | 2026-06-30 | $211.7m | 1,717,548 |  | Added +90,794 |
| [Jupiter Topco LLC](/funds/2146052.md) | 2026-06-30 | $211.3m | 1,713,595 |  | Not compared |
| [JANUS HENDERSON GROUP PLC](/funds/1274173.md) | 2026-03-31 | $164.7m | 1,905,920 |  | Not compared |
| [GEODE CAPITAL MANAGEMENT, LLC](/funds/1214717.md) | 2026-06-30 | $136.8m | 1,109,107 |  | Added +67,312 |
| [DIMENSIONAL FUND ADVISORS LP](/funds/354204.md) | 2026-06-30 | $130.8m | 1,061,434 |  | Added +14,584 |
| [VAUGHAN NELSON INVESTMENT MANAGEMENT, L.P.](/funds/1021642.md) | 2026-06-30 | $124.6m | 1,010,464 |  | Added +108,624 |

## Recent filings

[All 1,365 filings](/companies/sxt/filings.md)

| Filed | Accepted | Form | What it is | Accession |
| --- | --- | --- | --- | --- |
| 2026-10-30 | 11:53 ET | [10-Q](/filings/0001140361-26-041259.md) | Quarterly report, period 2026-09-30 | 0001140361-26-041259 |
| 2026-10-30 | 07:10 ET | [8-K](/filings/0001140361-26-041223.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-041223 |
| 2026-09-02 | 17:29 ET | [8-K](/filings/0001140361-26-035504.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-26-035504 |
| 2026-08-04 | 12:33 ET | [10-Q](/filings/0001140361-26-031094.md) | Quarterly report, period 2026-06-30 | 0001140361-26-031094 |
| 2026-07-24 | 07:10 ET | [8-K](/filings/0001140361-26-029501.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-029501 |
| 2026-06-23 | 17:00 ET | [8-K](/filings/0001140361-26-026110.md) | 1.01 Entry into a material agreement; 2.03 New direct financial obligation; 9.01 Financial statements and exhibits | 0001140361-26-026110 |
| 2026-05-05 | 12:32 ET | [10-Q](/filings/0001140361-26-019060.md) | Quarterly report, period 2026-03-31 | 0001140361-26-019060 |
| 2026-04-28 | 08:55 ET | [8-K](/filings/0001140361-26-017292.md) | 5.07 Shareholder vote results | 0001140361-26-017292 |
| 2026-04-24 | 07:04 ET | [8-K](/filings/0001140361-26-016575.md) | 2.02 Results of operations; 7.01 Regulation FD disclosure; 9.01 Financial statements and exhibits | 0001140361-26-016575 |
| 2026-03-11 | 09:16 ET | [DEF 14A](/filings/0001140361-26-008970.md) | Proxy statement, period 2026-04-23 | 0001140361-26-008970 |

## Latest annual report

[Form 10-K for the fiscal year ended Dec 31, 2025](/filings/0001140361-26-005311.md), filed Feb 13, 2026.

## Forecast league

Q3 FY2026, the quarter ended 2026-09-30, has been scored from the reported figures. [See the target](/leagues/2026q3/targets/90bf5de1-6fd8-43be-b602-5edf326d45a8)

## About the filer

- CIK: 310142
- Tickers: SXT
- Exchange: NYSE
- SIC code: 2860 Industrial Organic Chemicals
- State of incorporation: WI
- Filer category: Large accelerated filer

Source: SEC EDGAR, XBRL company facts, the filing index and Forms 4. Last ingested by Listed: Oct 31, 2026, 13:09 ET. No prices; not investment advice.